As we had observed enrichment of proliferation-related genes in NT tumors compared with tumors from STm-treated mice, and decreased tumor size, we assessed proliferation within tumors by Ki67 staining at 6 weeks after treatment. The gene discussed is MKI67; the disease is neoplasm.